Poison cassette exon splicing of SRSF6 regulates nuclear speckle dispersal and the response to hypoxia
| Autor: | Camila de Oliveira Freitas Machado, Michal Schafranek, Mirko Brüggemann, María Clara Hernández Cañás, Mario Keller, Antonella Di Liddo, Andre Brezski, Nicole Blümel, Benjamin Arnold, Anja Bremm, Ilka Wittig, Nicolas Jaé, François McNicoll, Stefanie Dimmeler, Kathi Zarnack, Michaela Müller-McNicoll |
|---|---|
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Nucleic Acids Research. 51:870-890 |
| ISSN: | 1362-4962 0305-1048 |
| Popis: | Hypoxia induces massive changes in alternative splicing (AS) to adapt cells to the lack of oxygen. Here, we identify the splicing factor SRSF6 as a key factor in the AS response to hypoxia. The SRSF6 level is strongly reduced in acute hypoxia, which serves a dual purpose: it allows for exon skipping and triggers the dispersal of nuclear speckles. Our data suggest that cells use dispersal of nuclear speckles to reprogram their gene expression during hypoxic adaptation and that SRSF6 plays an important role in cohesion of nuclear speckles. Down-regulation of SRSF6 is achieved through inclusion of a poison cassette exon (PCE) promoted by SRSF4. Removing the PCE 3′ splice site using CRISPR/Cas9 abolishes SRSF6 reduction in hypoxia. Aberrantly high SRSF6 levels in hypoxia attenuate hypoxia-mediated AS and impair dispersal of nuclear speckles. As a consequence, proliferation and genomic instability are increased, while the stress response is suppressed. The SRSF4–PCE–SRSF6 hypoxia axis is active in different cancer types, and high SRSF6 expression in hypoxic tumors correlates with a poor prognosis. We propose that the ultra-conserved PCE of SRSF6 acts as a tumor suppressor and that its inclusion in hypoxia is crucial to reduce SRSF6 levels. This may prevent tumor cells from entering the metastatic route of hypoxia adaptation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|